Carenostics vs Guidehealth (2026)
Finding the patient against acting on the finding. Carenostics reads the record, including the unstructured notes, to surface patients whose chronic disease is present and undiagnosed, with its own model so accuracy questions have one owner. Guidehealth pairs a predictive model with virtually embedded staff working under licensed supervision, on the premise that a practice which cannot staff the outreach will not benefit from knowing who to call. That is the real division. A candidate list nobody works is worth nothing, and staff with no targeting are expensive. If your network has capacity and needs precision, Carenostics. If your constraint is headcount, Guidehealth is selling the thing you are short of and should be priced against hiring.
- It finds patients who already have chronic disease nobody has diagnosed, reading existing record data including unstructured notes with its own model.
- Model ownership means accuracy questions have a single accountable party rather than routing to a partner.
- The output is a clinical finding that should lead to a workup rather than a documentation opportunity.
- It pairs a predictive model with virtually embedded staff trained in data science working under licensed clinical supervision.
- The institutional evidence is substantial, including adoption by a large academic health system.
- For a network without capacity to act on findings, buying the analytics and the people together is the difference between insight and outcome.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Carenostics and Guidehealth are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Carenostics | Guidehealth |
|---|---|---|
| Primary category | Clinical Decision Support | Value Based Care Intelligence |
| Founded | Not recorded | 2023 |
| Headquarters | Not recorded | Dallas, Texas, United States |
| Website | carenostics.com | guidehealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Carenostics its top capability grade on AI Centrality and Deployment Model and Data Residency. Set against Guidehealth, Carenostics grades higher on several axes, including AI Centrality, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Its thinnest published disclosure sits on several axes, including HIPAA and BAA Posture, Security Certifications and Trust Center and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index records no top capability grade for Guidehealth on any axis it scores. Set against Carenostics, Guidehealth grades higher on several axes, including Clinical and Operational Evidence, HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Carenostics or Guidehealth?
On the axes where the AI Health Index separates them, Carenostics grades higher on several axes, including AI Centrality, Model Supply Chain Disclosure and AI Safety and PHI Stewardship, and Guidehealth grades higher on several axes, including Clinical and Operational Evidence, HIPAA and BAA Posture and Security Certifications and Trust Center. Guidehealth leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Carenostics and Guidehealth differ most?
The widest separation the AI Health Index records between Carenostics and Guidehealth is on AI Centrality, where Carenostics grades A and Guidehealth grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Carenostics and Guidehealth grade the same?
The AI Health Index grades Carenostics and Guidehealth the same on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and FDA and Regulatory Status. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Carenostics and Guidehealth not disclosed?
At the last review, at least one of Carenostics and Guidehealth published thin or absent detail on several axes, including HIPAA and BAA Posture, Security Certifications and Trust Center and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Value Based Care Intelligence page.
Detection creates downstream cost the vendor does not carry, since a surfaced patient generates outreach, confirmatory testing and sometimes treatment, and in a value based contract that near term cost precedes any saving by years. Neither vendor publishes subgroup performance, which matters because a model deciding who is surfaced and a programme deciding who is contacted both fail quietly for the populations they reach least well. Guidehealth publishes no security material reachable from its own site, no business associate statement and no retention position.